News & Publications

Vigilant Biosciences® is proud to announce its participation in Dentistry Show London 2025, where it will highlight its groundbreaking BeVigilant™ OraFusion™ System — an advanced diagnostic solution designed to enable earlier detection of oral cancer and improve...

Lakeway, TX – Vigilant Biosciences is pleased to announce the successful approval of its BeVigilant™ OraFusion™ System under the In Vitro Diagnostic Regulation (IVDR), marking a significant milestone for international expansion. Additionally, Vigilant received...

Lakeway, TX – Vigilant Biosciences, a leader in the development of innovative solutions for the early detection of oral cancer, is pleased to announce that the U.S. Food and Drug Administration (FDA) has aligned on clinical requirements for a pivotal multi-site trial...

The BeVigilant™ OraFusion™ System was recently recognized by Inside Dentistry as one of the “10 Dental Technologies That Inspire for 2025.” The article spotlights our innovative, saliva-based test that enables early detection of oral cancer biomarkers right from the...

Breaking Cancer News dives into how Vigilant Biosciences® is advancing the early detection of oral cancer with its BeVigilant™ OraFusion™ System. The article features insights from oral surgeon Dr. William Shepard, who shares how this biomarker-driven saliva test is...

Dental Economics recently featured Vigilant Biosciences® and our BeVigilant™ OraFusion™ System in an article highlighting advancements in early oral cancer detection. The OraFusion System is a real-time, saliva-based test that enables dental professionals to identify...

We’re thrilled to see the BeVigilant™ OraFusion™ System featured in DSOPro as a key innovation shaping the future of DSOs. The article highlights how the BeVigilant™ OraFusion™ System enables clinicians to detect early signs of oral cancer in real-time, right from the...

We’re excited to see Dental Products Report highlight the BeVigilant™ OraFusion™ System as a powerful advancement in oral cancer detection. The article dives into how our technology leverages salivary biomarkers and AI to deliver real-time results chairside—giving...

Lifestyle factors play a major role in the development of oral cancer. Among the many clinical risk factors, smoking and alcohol top the list of behaviors that most directly increase a patient’s risk of oral cancer. Alone, smoking increases oral cancer risk by ten...

Lakeway, Texas (Date: 11-9-2023) – Vigilant Biosciences®, Inc. ("Vigilant"), an innovator and creator of solutions aimed at facilitating the early detection of oral cancer, is proud to announce the launch of its transformative product, the BeVigilant™ OraFusion™...